Expert Testimony

DFCR Letter to the House in Strong Support of the MORE Act

DFCR

2/24/22

Expert Testimony

Delaware House Health and Human Development Committee HB 305

David L. Nathan, MD, DFAPA

1/26/22

Expert Testimony

DFCR Letter to the House in Support of the MORE Act

DFCR

10/1/21

Expert Testimony

New Jersey Cannabis Regulatory Commission: High potency THC, Edibles

Mikhail Kogan, MD, ABOIM

6/2/21

Expert Testimony

Colorado House Public & Behavioral Health & Human Services HB21-1317

Bryon Adinoff, MD

5/18/21

Expert Testimony

Alabama House SB46

Bryon Adinoff, MD

4/26/21

Expert Testimony

Texas House Criminal Jurisprudence Committee HB3772

Bryon Adinoff, MD

4/20/21

Expert Testimony

Delaware House Human Health Committee HB150

David L. Nathan, MD, DFAPA

3/24/21

Expert Testimony

Delaware House Human Health Committee HB150

Bryon Adinoff, MD

3/24/21

Expert Testimony

Connecticut General Assembly Judiciary SB888

Hugh Blumenfeld, MD, PhD

3/1/21

Expert Testimony

Connecticut General Assembly Judiciary SB888

Bryon Adinoff, MD

2/25/21

Expert Testimony

New York Legislature CRTA

Tanya Adams, DO

2/23/21

Expert Testimony

New Jersey Senate Judiciary AB1898

David L. Nathan, MD, DFAPA

2/22/21

Expert Testimony

Virginia Senate: Adult Use Cannabis

Bryon Adinoff, MD

1/31/21

Expert Testimony

Comments in Response to the Cannabis Administration and Opportunity Act (CAOA)

DFCR

1/1/21

Expert Testimony

US Senate Cannabis Administration and Opportunity Act

Marijuana Justice Coalition

1/1/21

Expert Testimony

New Jersey Assembly Appropriations: Regulations

David L. Nathan, MD, DFAPA

11/20/20

Expert Testimony

New Jersey Assembly Oversight, Reform and Federal Relations

David L. Nathan, MD, DFAPA

11/10/20

Expert Testimony

Connecticut Senate Judiciary SB16

Bryon Adinoff, MD

3/3/20

Expert Testimony

Connecticut Senate Judiciary SB16

David L. Nathan, MD, DFAPA

3/3/20

Expert Testimony

US House Subcommittee Cannabis Policies for the New Decade

David L. Nathan, MD, DFAPA

1/18/20

Expert Testimony

Alabama House SB165

Donald O. Lyman, MD, DTPH

1/1/20

Expert Testimony

Alabama House SB165

Genester Wilson-King, MD, FACOG

1/1/20

Expert Testimony

Alabama House SB165

Wendy Askew, MD

1/1/20

Expert Testimony

New Jersey General Assembly CR840

Monica Taing, PharmD

12/12/19

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Bryon Adinoff, MD

10/23/19

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Genester Wilson-King, MD, FACOG

10/23/19

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Donald O. Lyman, MD, DTPH

10/23/19

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Rachel Knox, MD

10/23/19

Expert Testimony

Kansas Senate Federal and State Affairs SB366

Wendy Askew, MD

10/23/19

Expert Testimony

U.S. House: Congressional Committee Hearing on Cannabis Legalization

David L. Nathan, MD, DFAPA

7/10/19

Expert Testimony

Delaware House Revenue & Finance HB110

Bryon Adinoff, MD

6/5/19

Expert Testimony

Colorado Senate Medical Marijuana Code SB218

Bryon Adinoff, MD

5/10/19

Expert Testimony

Vermont House Government Operations SB54

David L. Nathan, MD, DFAPA

4/30/19

Expert Testimony

South Carolina Medical Affairs S.366

Bryon Adinoff, MD

4/6/19

Expert Testimony

South Carolina Medical Affairs S.366

Julia Arnsten, MD, MPH

4/1/19

Expert Testimony

New Jersey Senate Judiciary SB2703

David L. Nathan, MD, DFAPA

3/19/19

Expert Testimony

Texas House Public Health HB1365

Bryon Adinoff, MD

3/16/19

Expert Testimony

Texas House Criminal Jurisprudence HB63

Bryon Adinoff, MD

3/4/19

Expert Testimony

Vermont Senate Judiciary SB54

David L. Nathan, MD, DFAPA

2/1/19

Expert Testimony

New York General Assembly

Julia Arnsten, MD, MPH

12/1/18

Expert Testimony

New Jersey Senate Judiciary SB2703

Monica Taing, PharmD

11/1/18

Expert Testimony

New York Assembly Codes, Health, Governmental Operations, Alcoholism and Drug Abuse

David L. Nathan, MD, DFAPA

10/17/18

Expert Testimony

Connecticut Commission on Women, Children and Seniors Cannabis Forum (Video)

David L. Nathan, MD, DFAPA

4/30/18

Expert Testimony

New Jersey Division of Consumer Affairs Marijuana Reclassification

David L. Nathan, MD, DFAPA

4/25/18

Expert Testimony

U.S. FDA Cannabis Scheduling

David L. Nathan, MD, DFAPA

4/23/18

Expert Testimony

New Jersey Assembly Oversight, Reform and Federal Relations Committee on Cannabis Legalization

David L. Nathan, MD, DFAPA

3/6/18

Expert Testimony

Illinois General Assembly SB316

David L. Nathan, MD, DFAPA

1/23/18

Expert Testimony

Testimony before the Illinois Senate on Marijuana Legalization

Leslie Mendoza Temple, MD, ABOIM

1/22/18

Expert Testimony

New Jersey Senate Judiciary Cannabis Adult Use

David L. Nathan, MD, DFAPA

6/19/17

Expert Testimony

Delaware House Revenue & Finance HB110

David L. Nathan, MD, DFAPA

5/11/17

Expert Testimony

Texas House Criminal Jurisprudence HB2107

Bryon Adinoff, MD

5/3/17

Expert Testimony

California State Assembly AB1606

DFCR

4/14/17

Expert Testimony

Vermont House Human Services H.170

Bryon Adinoff, MD

4/12/17

Expert Testimony

Rhode Island House Judiciary HB5555

David L. Nathan, MD, DFAPA

4/12/17

Expert Testimony

Texas House Criminal Jurisprudence HB81

Bryon Adinoff, MD

3/14/17

Expert Testimony

New Jersey Senate Judiciary

David L. Nathan, MD, DFAPA

11/17/15

Expert Testimony

Categories

Browse by Location

Follow

Contact Us

DFCR News & Events